Amy E. Juedes

Array ( [id] => 11123415 [patent_doc_number] => 20160320388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'BIOMARKERS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/180377 [patent_app_country] => US [patent_app_date] => 2016-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 50434 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15180377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11335659 [patent_doc_number] => 20160361414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-15 [patent_title] => 'Methods of Treating and Preventing Minor Histocompatibility Antigen-Mismatched Grafts' [patent_app_type] => utility [patent_app_number] => 15/181115 [patent_app_country] => US [patent_app_date] => 2016-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7681 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15181115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14497821 [patent_doc_number] => 20190192565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => METHODS TO INDUCE CONVERSION OF REGULATORY T CELLS INTO EFFECTOR T CELLS FOR CANCER IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 15/578871 [patent_app_country] => US [patent_app_date] => 2016-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21576 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15578871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13371987 [patent_doc_number] => 20180237534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-23 [patent_title] => ANTIBODIES AGAINST OX40 AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/577375 [patent_app_country] => US [patent_app_date] => 2016-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 93202 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15577375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11813844 [patent_doc_number] => 09717777 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-01 [patent_title] => 'Use of CCL1 in therapy' [patent_app_type] => utility [patent_app_number] => 15/163689 [patent_app_country] => US [patent_app_date] => 2016-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 29 [patent_no_of_words] => 20534 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15163689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11290718 [patent_doc_number] => 20160340650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-24 [patent_title] => 'BLOOD DERIVED IMMUNE STIMULATORY COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 15/162352 [patent_app_country] => US [patent_app_date] => 2016-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1461 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15162352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12808588 [patent_doc_number] => 20180161366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-14 [patent_title] => METHODS OF OBTAINING MONONUCLEAR BLOOD CELLS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/571069 [patent_app_country] => US [patent_app_date] => 2016-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20849 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15571069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11289023 [patent_doc_number] => 20160338955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-24 [patent_title] => 'ANTIGEN-SPECIFIC IMMUNOTHERAPY USING TOLERIZING LIPOSOMES' [patent_app_type] => utility [patent_app_number] => 15/158818 [patent_app_country] => US [patent_app_date] => 2016-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58437 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15158818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17363570 [patent_doc_number] => 11230587 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-25 [patent_title] => Ligands of B7H receptor in the treatment of osteopenia and osteoporosis [patent_app_type] => utility [patent_app_number] => 15/576789 [patent_app_country] => US [patent_app_date] => 2016-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 8357 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15576789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11127804 [patent_doc_number] => 20160324779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-10 [patent_title] => 'Targeted Lipid-Drug Formulations for Delivery of Drugs to Myeloid and Lymphoid Immune Cells' [patent_app_type] => utility [patent_app_number] => 15/154097 [patent_app_country] => US [patent_app_date] => 2016-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19374 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15154097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12707653 [patent_doc_number] => 20180127717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => DENDRITIC CELL IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 15/572161 [patent_app_country] => US [patent_app_date] => 2016-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15916 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -78 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15572161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12790771 [patent_doc_number] => 20180155426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => MODULATION OF IMMUNE RESPONSE USING BTLA AGONIST ANTIBODIES [patent_app_type] => utility [patent_app_number] => 15/570013 [patent_app_country] => US [patent_app_date] => 2016-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5980 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11083825 [patent_doc_number] => 20160280790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-29 [patent_title] => 'DEPLETION OF PLASMACYTOID DENDRITIC CELLS' [patent_app_type] => utility [patent_app_number] => 15/092275 [patent_app_country] => US [patent_app_date] => 2016-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 15302 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15092275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11016809 [patent_doc_number] => 20160213761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-28 [patent_title] => 'CARBON NANOTUBE COMPOSITIONS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/090927 [patent_app_country] => US [patent_app_date] => 2016-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 28339 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15090927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14227351 [patent_doc_number] => 20190125848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-02 [patent_title] => DENDRITIC CELL-EXTRACELLULAR VESICLE FUSIONS AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 16/088977 [patent_app_country] => US [patent_app_date] => 2016-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7485 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11075748 [patent_doc_number] => 20160272713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'Fibrosis Inhibiting Compounds and Methods of Use Thereof in the Prevention or Treatment of Fibrosing Diseases' [patent_app_type] => utility [patent_app_number] => 15/083989 [patent_app_country] => US [patent_app_date] => 2016-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8707 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15083989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11009765 [patent_doc_number] => 20160206718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'Compositions for Liquidation of Tumors' [patent_app_type] => utility [patent_app_number] => 15/084206 [patent_app_country] => US [patent_app_date] => 2016-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6801 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15084206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12259431 [patent_doc_number] => 20180078627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-22 [patent_title] => 'METHOD FOR ANTIGEN LOADING OF DENDRITIC CELLS AND VACCINE' [patent_app_type] => utility [patent_app_number] => 15/563542 [patent_app_country] => US [patent_app_date] => 2016-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12814 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11085397 [patent_doc_number] => 20160282363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-29 [patent_title] => 'Methods of Treating Subjects having Severe and/or Persistent Asthma' [patent_app_type] => utility [patent_app_number] => 15/080972 [patent_app_country] => US [patent_app_date] => 2016-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 28694 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15080972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11393915 [patent_doc_number] => 20170014451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-19 [patent_title] => 'COMPOSITIONS AND METHODS OF TREATING T CELL MEDIATED DISORDER' [patent_app_type] => utility [patent_app_number] => 15/077256 [patent_app_country] => US [patent_app_date] => 2016-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15076 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15077256 [rel_patent_id] =>[rel_patent_doc_number] =>)